---
type: wiki
title: Healthcare Governance Packet — Recursive Governance for Providers
aliases:
- Healthcare Governance Packet
tags:
- areas
- recursion
- governance
- healthcare-governance-packet-recursive-governance-for-providers-md
- healthcare
- pass
- discharge
- blocked
- clinical
- color-purple
status: active
created: '2026-06-21'
updated: '2026-06-26'
vault_area: Areas
canonical_path: Areas/PHAROS/Healthcare Governance Packet — Recursive Governance for Providers.md
backlink_count: 26
backlinks:
- '[[wiki/AI Governance Failure Cases]]'
- '[[Areas/PHAROS/Bonded Intelligence Under Constraint — The LOTUS Processor Framework]]'
- '[[Areas/Personal/CDPDJ Complaint — Lepage v Calian and Novartis]]'
- '[[wiki/Care, Ethics, and Governance]]'
- '[[wiki/Consent and Boundary Frameworks]]'
- '[[wiki/Disability Epistemology and Institutional Critique]]'
- '[[Areas/Writing/Embedding Before Rupture — Relational AI and Institutional Power]]'
- '[[Areas/PHAROS/Governance and PHAROS MOC]]'
- '[[Areas/PHAROS/Governance and Platform Signals Memo — 2026-05-14]]'
- '[[Areas/PHAROS/Harrowfield Clinic — AI Governance Failure Case Study]]'
- '[[Areas/Writing/Healthcare Packet — Version Genealogy]]'
- '[[wiki/Home]]'
- '[[wiki/LOTUS Model and Agency]]'
- '[[Areas/PHAROS/LOTUS Model — Agency and Social Positioning]]'
- '[[Areas/PHAROS/Martin Lepage — Professional Profile]]'
- '[[wiki/Mort et Naissance et L''Ombre et le Double — MA Thesis on Yvon Rivard (Université Laval, 2010)]]'
- '[[wiki/Mythocritique to PHAROS — The 2010 Master''s Thesis as Methodological Keystone]]'
- '[[Resources/Regulatory Standards Reference Stack — Governance Controls Grounding]]'
- '[[Areas/Writing/Research and Papers MOC]]'
- '[[wiki/Responsible AI Evaluation — Patient Readmission Model]]'
- '[[wiki/September 2024 Research Retrospective]]'
- '[[wiki/Vault Cluster Discovery and Linking Opportunities — 2026-05-01]]'
- '[[wiki/Vault Linking Gaps & Bridge Opportunities — 2026-05-01]]'
- '[[_vault/VAULT ADDITIONS TRACKER]]'
- '[[archive/session-state/session-state-001]]'
- '[[maps/PHAROS Method Map]]'
---

# Healthcare Governance Packet — Recursive Governance for Providers

## Summary
A 13-pass recursive governance framework for healthcare providers, under limited internal circulation (v3). The validation discharge is still blocked as of the document version. Applies the [[Recursive Deterministic AI Governance — Method and Paper]] method to the specific accountability conditions of healthcare AI deployment — regulated environment, life-consequence decisions, multi-jurisdictional liability. Related to [[PHAROS Invention Disclosure]] and [[PHAROS Runbook SOP]]. Operational reference for [[Consent and Boundary Frameworks]] — informed consent in clinical AI is a boundary condition, not a one-time permission.

## Context
Source: `Governance_and_Trust_Packet_System_Healthcare_Providers_Limited_Internal_Circulation_v3.docx`. This is a client-facing or partner-facing document, not a public paper. "Limited internal circulation" indicates it is being shared with healthcare provider stakeholders who are evaluating or piloting the PHAROS method. The 13-pass structure mirrors the 12-stage pipeline from the [[PHAROS Invention Disclosure]] plus an additional healthcare-specific pass. The Osirian death/rebirth structure underlying the recursive pipeline is documented in [[Mythocritique to PHAROS — The 2010 Master's Thesis as Methodological Keystone|the keystone]]; the 13-pass healthcare extension preserves that initiatic structure for clinical-AI deployment contexts.

---

## The 13-Pass Structure

Standard PHAROS pipeline runs 12 stages. The healthcare version adds a 13th pass for regulatory compliance verification — checking whether the governance outcome aligns with the applicable healthcare regulatory framework (Canadian provincial, federal, HIPAA if US-adjacent, etc.).

The 13 passes are grouped into three phases:

### Phase 1 — Corpus Governance (Passes 1-4)
- Pass 1: Corpus formation with healthcare data admissibility classification (PHI handling, consent status, data provenance)
- Pass 2: Regulatory framework mapping (which jurisdiction's rules apply to this corpus)
- Pass 3: Target construct mapping (which TC-1 through TC-5 apply to this healthcare use case)
- Pass 4: Admissibility boundary confirmation (what is in scope vs. out of scope for this patient population or clinical context)

### Phase 2 — Recursive Governance (Passes 5-10)
- Pass 5: Recursive transformation Pass 1
- Pass 6: Failure harvesting (clinical errors, misclassifications, boundary violations)
- Pass 7: Recursive transformation Pass 2
- Pass 8: Drift detection (specifically checking for outcome drift correlated with protected characteristics — race, gender, age, disability)
- Pass 9: Deterministic rollup (12-rule logic applied to healthcare context)
- Pass 10: Adjudication (6-step protocol for contested healthcare governance decisions)

### Phase 3 — Validation and Discharge (Passes 11-13)
- Pass 11: Consequence binding (mapping to institutional infrastructure — EHR system, clinical workflow, escalation protocol)
- Pass 12: Promotion decision with healthcare liability notation
- Pass 13: Regulatory compliance verification (the additional healthcare-specific pass)

---

## Validation Discharge — Still Blocked

As of v3, the validation discharge is blocked. This is significant: it means the packet has not yet been certified as ready for deployment in live clinical contexts.

**Named blocker category**: evidential gap in Pass 8 (drift detection). The document indicates that drift detection data — specifically outcome data disaggregated by protected characteristics — was not available from the pilot client, making Pass 8 incomplete. Under the 12-rule rollup logic, an incomplete TC produces `incomplete` status, which blocks the validation discharge.

**Governance consequence**: the packet is marked `blocked_not_ready` pending Pass 8 completion. The blocked status is explicit — the document does not work around it or claim conditional readiness.

**What is needed to discharge**: the pilot client needs to provide outcome data disaggregated by protected characteristics (race, gender, age, disability) for the clinical AI system under evaluation. Without this data, drift detection cannot be run, and the validation cannot proceed.

This is the [[PHAROS Invention Disclosure]]'s `incomplete` status in a real deployment context: the pipeline cannot produce a promotion decision until all required passes have been run.

---

## Healthcare-Specific Governance Requirements

The packet identifies several requirements specific to healthcare contexts that are not present in the general PHAROS method:

### Consent and Data Provenance
Every corpus item (patient record, clinical output, diagnostic result) must carry explicit consent documentation and data provenance chain. The admissibility boundary (Pass 1) is stricter than in non-healthcare contexts: items with unclear provenance are classified `excluded`, not `adjacent`.

### Liability Notation
Promotion decisions in healthcare contexts require an explicit liability notation: which entity (provider, AI developer, healthcare organization) is accountable for the promoted output, under what regulatory framework, and under what conditions the liability chain breaks.

### Escalation Protocol
The consequence binding (Pass 11) in healthcare must include an escalation protocol for `blocked_not_ready` decisions: who is notified, within what timeframe, through what channel. Unlike non-healthcare contexts where a blocked decision can sit in the governance queue, a blocked healthcare decision may require immediate clinical escalation.

### Outcome Monitoring
The 13th pass is not a one-time certification. It is designed to be re-run at defined intervals (the packet recommends quarterly for high-risk clinical AI systems) to detect regulatory drift — changes in the applicable regulatory framework that might change the governance status of an already-promoted output.

---

## Limited Internal Circulation — What This Means

The "limited internal circulation" classification indicates:

1. The document is not public; it is shared only with named stakeholders
2. It has not been through the full publication review that the academic papers have
3. It represents the applied / commercial face of the PHAROS method, not the academic / theoretical face
4. The blocked validation discharge makes public circulation premature — you would not share a governance certification that hasn't certified anything yet

---

## Insights

- The blocked validation discharge is the most important data point in this document. It demonstrates that the PHAROS method produces real `blocked_not_ready` decisions — it is not a system that always finds a way to proceed. This is evidence of governance integrity: the method held the line
- Drift detection (Pass 8) being the specific blocker is not accidental. Outcome data disaggregated by protected characteristics is the hardest data to obtain and the most important data for healthcare AI governance. The block is on the most consequential pass
- The 13th pass (regulatory compliance verification as a recurring obligation) reframes governance from an event to a process: a governance decision is not final; it must be re-validated as the regulatory context changes
- "Limited internal circulation" is a governance status, not a confidentiality classification. It says: this document is in a state where it should not be cited publicly as certified. The distinction matters — it is not secret, it is provisional

## Open Questions

- Which pilot client provided the data for v3? Is this a Quebec healthcare provider?
- What is the timeline for unblocking Pass 8 — has the pilot client agreed to provide disaggregated outcome data?
- Is there a v4 that resolves the blocked discharge?
- How does the 13th pass re-run process work in practice — is it automated or manual?

## Sources
- `raw sources/Governance_and_Trust_Packet_System_Healthcare_Providers_Limited_Internal_Circulation_v3.docx`
- Related: [[Recursive Deterministic AI Governance — Method and Paper]]
- Related: [[PHAROS Invention Disclosure]]
- Related: [[PHAROS Runbook SOP]]
- Related: [[Martin Lepage — Professional Profile]]
- Related: [[Fluency, Interruption, and Institutional Accountability]]
- Version genealogy: [[Healthcare Packet — Version Genealogy]]
